Jose Antonio Perez Simon

Profesor Titular de Universidad (Pza. V)
jperezsimon-ibis@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: SERVICIO HEMATOLOGIA-HEMOTERAPIA. H.U. VIRGEN DEL ROCIO (CTS-219)
Instituto de Inv.: IBIS
Prog. doctorado: Prog.Doct.en Biología Molecular, Biomedicina e Investigac.Clínica (RD.2011)
Tipo Año Título Fuente
Artículo2021 Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study BONE MARROW TRANSPLANTATION
Artículo2021 Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial ANNALS OF HEMATOLOGY
Corrección2021 Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial (Annals of Hematology, (2021), 100, 5, (1181-1194), 10.1007/s00277-021-04465-4) ANNALS OF HEMATOLOGY
Artículo2021 Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia LEUKEMIA
Artículo2021 Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases Antibiotics
Artículo2021 Long-term outcomes after autologous versus allogeneic stem cell transplantation in molecularly-stratified patients with intermediate cytogenetic risk acute myeloid leukemia: a PETHEMA study Transplantation and Cellular Therapy
Artículo2021 MUFAs in High-Fat Diets Protect against Obesity-Induced Bias of Hematopoietic Cell Lineages MOLECULAR NUTRITION & FOOD RESEARCH
Artículo2021 Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT BONE MARROW TRANSPLANTATION
Artículo2020 ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype CANCER MEDICINE
Corrección2020 Corrigendum to “Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study” [Leuk. Res. 92 (March) (2020) 106352] (Leukemia Research (2020) 92, (S0145212620300576), (10.1016/j.leukres.2020.106352)) LEUKEMIA RESEARCH
Artículo2020 Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model Cancer Immunology, Immunotherapy
Artículo2020 Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? LEUKEMIA
Artículo2020 First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia JOURNAL OF CLINICAL ONCOLOGY
Revisión2020 Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions Blood Reviews
Artículo2020 Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation BONE MARROW TRANSPLANTATION
Artículo2020 Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project HAEMATOLOGICA
Revisión2020 Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma FRONTIERS IN IMMUNOLOGY
Artículo2020 Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study LEUKEMIA RESEARCH
Letter2020 Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors BONE MARROW TRANSPLANTATION
Letter2020 T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients HAEMATOLOGICA
Revisión2020 The role of TNFR2 and DR3 in the in vivo expansion of tregs in t cell depleting transplantation regimens INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículo2020 Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT BONE MARROW TRANSPLANTATION
Artículo2020 Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab LEUKEMIA
Artículo2019 A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients LEUKEMIA RESEARCH
Artículo2019 Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2019 Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation BONE MARROW TRANSPLANTATION
Artículo2019 Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH) EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2019 Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party BONE MARROW TRANSPLANTATION
Artículo2019 Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists INVESTIGATIONAL NEW DRUGS
Letter2019 HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT CELLULAR & MOLECULAR IMMUNOLOGY
Resumen congreso2019 Influence of basic parameters of hemostasis in the hemorrhagic profile of the chronic PTI HAEMATOLOGICA
Resumen congreso2019 Mutational profile in patients with low-risk myelodysplastic syndrome at the time of progression to acute leukemia HAEMATOLOGICA
Artículo2019 Polyphenolic Extract (PE) from Olive Oil Exerts a Potent Immunomodulatory Effect and Prevents Graft-versus-Host Disease in a Mouse Model BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study BONE MARROW TRANSPLANTATION
Resumen congreso2019 Sequential cumulative effect on the alfa diversity of the intestinal microbiota of honey-binding conditions and active antibiotics against gram-negatives HAEMATOLOGICA
Artículo2019 Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms CLINICAL CANCER RESEARCH
Artículo2018 A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia ANNALS OF HEMATOLOGY
Corrección2018 A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia (vol 97, pg 763, 2018) ANNALS OF HEMATOLOGY
Letter2018 Clinical association of anti-glutathione S-transferase T1 antibodies and de novo immune hepatitis after hematopoietic cell transplantation DIGESTIVE AND LIVER DISEASE
Artículo2018 De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation Transplant Immunology
Resumen congreso2018 European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients BONE MARROW TRANSPLANTATION
Artículo2018 Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2018 FOUR CASES OF MYELOID NEOPLASM RELATED TO THERAPEUTICS IN THE CONTEXT OF TREATMENT OF SARCOMAS IN FLABBY PARTS HAEMATOLOGICA
Resumen congreso2018 IBRUTINIB - RELATED TOXICITY AND SUSPENSION OF TREATMENT HAEMATOLOGICA
Artículo2018 IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q-AML ONCOIMMUNOLOGY
Letter2018 KIT D816V-chronic myelomonocytic leukemia progressing to KIT D816V+associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation ANNALS OF HEMATOLOGY
Artículo2018 Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility TRANSFUSION
Artículo2018 PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation ANNALS OF HEMATOLOGY
Resumen congreso2018 Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia BLOOD
Resumen congreso2018 PROGNOSTIC VALUE OF PRE-ALOTPH EMR IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA HAEMATOLOGICA
Resumen congreso2018 RATIO OF ABSOLUTE CIRCULATING LYMPHOCYTES/MONOCYTES AS A PROGNOSTIC FACTOR IN THE DLCL-B TO DIAGNOSIS HAEMATOLOGICA
Resumen congreso2018 RESULTS OF TREATMENT GUIDED BY PET/INTERMEDIATE TAC IN PATIENTS WITH DIAGNOSIS OF LYMPHOMA B DIFFUSE OF LARGE CELLS (LBDCG). EXPERIENCE OF A CENTER HAEMATOLOGICA
Artículo2018 RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation CELL DEATH & DISEASE
Artículo2018 Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology" FRONTIERS IN IMMUNOLOGY
Artículo2018 Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation MABS
Resumen congreso2018 USE OF SORAFENIB IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA FLT3-ITD POSITIVE IN SITUATION OF RELAPSE OR REFRACTORINESS: RECENT EXPERIENCE OF A CENTER HAEMATOLOGICA
Revisión2018 Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Resumen congreso2018 WHAT CAN WE CONCLUDE FROM RUXOLITINIB AFTER MORE THAN 5 YEARS OF EXPERIENCE WITH THE DRUG? HAEMATOLOGICA
Resumen congreso2017 ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE, EXPERIENCE IN A SINGLE CENTER HAEMATOLOGICA
Resumen congreso2017 ANAGRELIDE RESPONSE ACCORDING TO THE MOLECULAR PROFILE: SOMETHING TO CONCLUDE ON THE MECHANISM OF ACTION OF THE DRUG IN MYELOPROLIFERATIVE NEOPLASMS (MPN)? HAEMATOLOGICA
Resumen congreso2017 ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH MYELODISPLASIC SYNDROME SUBJECTED TO ALOGENIC TRANSPLANT OF HEMATOPOYETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2017 ANALYSIS OF THE INCIDENCE AND CAUSES OF ADMISSION IN THE ICU IN LARGE COHORT OF ADULT PATIENTS SUBJECTED TO HEMATOPOYETIC TRANSPLANTATION HAEMATOLOGICA
Resumen congreso2017 ASSESSING PROGNOSIS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES. PARAMETERS RELATED TO THE PROBABILITY OF LEUKEMIC PROGRESSION LEUKEMIA RESEARCH
Letter2017 Candida parapsilosis misleading the automated absolute and differential white blood cell count ANNALS OF HEMATOLOGY
Resumen congreso2017 COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF EXTRACORPOREAL PHOTOPHERESIS AS A RESCUE TREATMENT OF THE CHRONIC EICR ACCORDING TO OPEN OR CLOSED SYSTEM: EXPERIENCE OF TWO CENTERS HAEMATOLOGICA
Artículo2017 Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis EXPERIMENTAL HEMATOLGY & ONCOLOGY
Resumen congreso2017 Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression BLOOD
Resumen congreso2017 DISCONTINUING ANTIBACTERIAL THERAPY AFTER APYREXIA AND CLINICAL STABILITY REGARDLESS OF NEUTROPHIL COUNT IN FEBRIL NEUTROPENIA IS SAFE AND REDUCES EXPOSITION TO ANTIBIOTICS (HOWLONG RANDOMIZED TRIAL) HAEMATOLOGICA
Artículo2017 Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2017 EUROPEAN MYELOMA NETWORK CLINICAL TRIAL PHASE I (ALLO-EMN) OF ALLOGENIC TRANSPLANTATION IN PATIENTS WITH HIGH RISK MULTIPLE MYELOMA (MM) HAEMATOLOGICA
Resumen congreso2017 Improvement of outcome after autologous stem cell transplantation by reduction of infections and SOS/VOD syndrome's related mortality: 28 years single-center experience BONE MARROW TRANSPLANTATION
Resumen congreso2017 Is idiopathic myelofibrosis (MFI) with V617 JAK2 mutation is the same entity as secondary myelofibrosis (MFS) to evolution of mutated myeloproliferative neoplasm (MPN)? HAEMATOLOGICA
Artículo2017 Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier TRANSLATIONAL RESEARCH
Resumen congreso2017 MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS AND TRANSPLANT RECIPIENTS OF HEMATOPOIETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2017 MULTICENTRIC STUDY ON THE USE OF RUXOLITINIB IN ACUTE AND REFRACTORY CHRONIC EICH IN ONE OR MORE TREATMENT LINES. RESULTS OF OUR EXPERIENCE HAEMATOLOGICA
Artículo2017 Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial LANCET HAEMATOLOGY
Letter2017 Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab BLOOD
Resumen congreso2017 POLYGLOBULIA IN THE YOUNG MAN IN THE AGE OF HEALTH CONTROLS: NEED FOR NEW PHYSIOLOGICAL RANGES OR EXCEPTION TO THE WHO 2016 CLASSIFICATION? HAEMATOLOGICA
Resumen congreso2017 Prognostic evaluation in patients with low risk myelodysplastic syndrome parameters related to the probability of leukemic progression HAEMATOLOGICA
Resumen congreso2017 Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study BLOOD
Resumen congreso2017 Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm BLOOD
Artículo2017 Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2017 THE 1RC STATUS AND THE NEW DIAGNOSIS ARE ASSOCIATED WITH BETTER LONG-TERM SURVIVAL IN ALLOTRANSPLANTED PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA HAEMATOLOGICA
Resumen congreso2017 THE COMBINED TREATMENT WITH AAS AND HEPARIN OF LOW MOLECULAR WEIGHT IS EFFECTIVE IN THE PREVENTION OF THROMBOSIS IN PREGNANT WOMEN WITH MYELOPROLIFERATIVE NEOPLASMS HAEMATOLOGICA
Artículo2017 The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome LEUKEMIA & LYMPHOMA
Resumen congreso2017 THE PROBABILITY OF CONCLUDING ALLOGENIC TRANSPLANTATION FROM ITS INDICATION IS SIMILAR TO HAVING OR NOT HAVING HISTOCOMPATIBLE SIBLING: SELECTION STRATEGY BASED ON THE PREFERENTIAL USE OF UNRELATED DONOR (ND) AS AN ALTERNATIVE SOURCE OF HAEMATOPOIETIC PROGENITORS (HP) HAEMATOLOGICA
Resumen congreso2017 TO SUSPEND THE EMPIRICAL ANTIMICROBIAL TREATMENT AFTER THREE DAYS OF APYREXIA IN HEMATOLOGICAL PATIENTS WITH FEBRILE NEUTROPENIA IS SAFE AND REDUCES UNNECESSARY EXPOSURE TO ANTIBIOTICS: FINAL RESULTS OF THE RANDOMIZED CLINICAL TRIAL HOW LONG HAEMATOLOGICA
Artículo2017 Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting LEUKEMIA & LYMPHOMA
Artículo2016 Caspase-8 inhibition represses initial human monocyte activation in septic shock model ONCOTARGET
Artículo2016 Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Letter2016 GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study BONE MARROW TRANSPLANTATION
Artículo2016 Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis BLOOD
Artículo2016 Immunotherapeutic targeting of LIGHT/LT beta R/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells MABS
Artículo2016 Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation Hematology
Letter2016 Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo2016 Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm DIAGNOSTIC CYTOPATHOLOGY
Resumen congreso2016 THE INCORPORATION OF COMORBIDITIES IN THE PROGNOSTICATION OF PATIENTS WITH LOWER-RISK MDS HAEMATOLOGICA
Editorial2015 Anti-common gamma-chain antibody: one for all in GVHD BLOOD
Artículo2015 Black Bone Marrow Variable Cytoplasmic Melanin Content in Malignant Melanoma Cells in Bone Marrow Aspirate DIAGNOSTIC CYTOPATHOLOGY
Resumen congreso2015 CHARACTERISTICS OF ONCOHEMATOLOGICAL PATIENTS ADMITTED IN THE INTENSIVE CARE UNIT (UCI): COMPARISION BETWEEN THE PATIENTS SUBJECTED TO TRANSPLANT OF HEMATOPOIETIC PROGENITORS AND NON TRANSPLANTATION (NO-TPH) HAEMATOLOGICA
Artículo2015 Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase inhibitors in Paediatric Acute Lymphoblastic Leukaemia ACTA HAEMATOLOGICA
Artículo2015 Evaluation of a method for murine monocyte isolation by bone marrow depletion ANALYTICAL BIOCHEMISTRY
Artículo2015 GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT BONE MARROW TRANSPLANTATION
Artículo2015 Human Bone Marrow Stromal Cells Differentiate Into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice Cell Transplantation
Resumen congreso2015 IMPLICATIONES OF THE ADVERSE KARYOTYPE IN PATIENTS WITH MYELODYSPPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA. EXPERIENCE OF A CENTRE HAEMATOLOGICA
Artículo2015 Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2015 Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure TRANSFUSION
Resumen congreso2015 MISMATCH ON GLUTATHIONE S-TRANSFERASE T1 INCREASES THE RISK OF GRAFT-VERSUS-HOST DISEASE AND MORTALITY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION TISSUE ANTIGENS
Resumen congreso2015 MUCORMYCOSIS IN ONCOHAEMATOLOGICAL PATIENTS AND RECEPTORS OF TRASPLANTS OF HAEMOTOPOIETIC PROGENITORS. EXPERIENCE OF THE LAST 10 YEARS OF A SINGLE CENTRE HAEMATOLOGICA
Artículo2015 Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score LEUKEMIA RESEARCH
Letter2015 Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality MEDICINA CLINICA
Artículo2015 Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells American Journal of Cancer Research
Artículo2015 Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2015 Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study HAEMATOLOGICA
Resumen congreso2015 Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia BLOOD
Resumen congreso2015 PROGNOSTIC VALUE OF THE EVALUATION OF THE PRETRANSPLANT ALLOGENEIC CARDIAC FUNCTION HAEMATOLOGICA
Resumen congreso2015 Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation BLOOD
Artículo2015 PTPN13 and beta-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche STEM CELL REPORTS
Resumen congreso2015 THE ADDITION OF COMORBIDITY ALLOWS A BETTER STRATIFICATION AND DEVELOPMENT OF A SPECIFIC PROGNOSTIC SCORE IN THE GROUP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW RISK BY IPSS HAEMATOLOGICA
Artículo2015 The CD27(+) memory B cells display changes in the gene expression pattern in elderly individuals IMMUNOLOGY
Resumen congreso2015 THE INVASIVE FUNGAL INFECTION IS A CLINICALLY RELEVANT CAUSE OF MORTALITY AND MORBIDITY IN PATIENTS WITH LYMPHOPROLIFERATIVE SYNDROMES HAEMATOLOGICA
Artículo2014 An Active Isodicentric X Chromosome in a Case of Refractory Anaemia with Ring Sideroblasts Associated with Marked Thrombocytosis Case Reports in Genetics
Resumen congreso2014 AZACITIDINE IMPROVES SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WITH 20-30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETIC CATEGOR HAEMATOLOGICA
Artículo2014 Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014 Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2014 Gene and miRNA Expression Profiles of Hematopoietic Progenitor Cells Vary Depending on Their Origin BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014 Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34(+) cells from healthy donors HAEMATOLOGICA
Artículo2014 Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014 Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2014 Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2014 PTPN13 regulates cellular signalling and beta-catenin function during megakaryocytic differentiation BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Artículo2014 Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus BONE MARROW TRANSPLANTATION
Resumen congreso2014 Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients BLOOD
Artículo2014 Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Editorial2014 Severe hemophagocytosis syndrome: macrophage cannibalism EUROPEAN JOURNAL OF HAEMATOLOGY
Resumen congreso2013 Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation BLOOD
Artículo2013 Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2013 Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis Leukemia Research Reports
Resumen congreso2013 EARLY DETECTION OF SERUM GALACTOMANNAN ANTIGEN IN HEMATOLOGIC MALIGNANCIES: IMPACT OF A LABORATORY ASSAY IN ASPERGILLUS INFECTION MORTALITY RATE HAEMATOLOGICA
Resumen congreso2013 Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma BLOOD
Resumen congreso2013 GSTT1 mismatch constitutes a risk factor for acute and chronic hepatic GVHD and influences patient survival BONE MARROW TRANSPLANTATION
Resumen congreso2013 Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance? LEUKEMIA RESEARCH
Artículo2013 Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2013 Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy TRANSPLANTATION PROCEEDINGS
Artículo2013 In Vitro Simulation of Corneal Epithelium Microenvironment Induces a Corneal Epithelial-like Cell Phenotype from Human Adipose Tissue Mesenchymal Stem Cells CURRENT EYE RESEARCH
Artículo2013 Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients BONE MARROW TRANSPLANTATION
Revisión2013 LIGHT/HVEM/LTR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation AMERICAN JOURNAL OF TRANSPLANTATION
Resumen congreso2013 Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals BLOOD
Resumen congreso2013 Mobilization Scheme With Cytarabine In Poor Mobilizers Patients Diagnosed With Lymphoma BLOOD
Resumen congreso2013 Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score BLOOD
Resumen congreso2013 Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell BLOOD
Resumen congreso2013 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis LEUKEMIA RESEARCH
Artículo2013 Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients BRITISH JOURNAL OF HAEMATOLOGY
Artículo2013 The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate HAEMATOLOGICA
Artículo2013 To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2013 Uptake and delivery of antigens by mesenchymal stromal cells CYTOTHERAPY
Artículo2012 Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation TRANSFUSION
Resumen congreso2012 Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system HAEMATOLOGICA
Artículo2012 Development of a Population-Based Cost-Effectiveness Model of Chronic Graft-Versus-Host Disease in Spain CLINICAL THERAPEUTICS
Artículo2012 Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment LEUKEMIA RESEARCH
Artículo2012 Evaluation of prognostic factors among patients with chronic graft-versus-host disease HAEMATOLOGICA
Resumen congreso2012 Impact of V617F mutation in the management of thrombotic risk in patients with essential thrombocytemia HAEMATOLOGICA
Artículo2012 Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning BONE MARROW TRANSPLANTATION
Resumen congreso2012 Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features BLOOD
Resumen congreso2012 Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis BLOOD
Artículo2012 The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation HAEMATOLOGICA
Resumen congreso2012 To freeze or not to freeze haematopoietic stem cells prior to allogeneic transplantation BONE MARROW TRANSPLANTATION
Letter2011 Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloma: It's Time for the Appropriate Studies Reply JOURNAL OF CLINICAL ONCOLOGY
Artículo2011 B- and T-Lymphocyte Attenuator Targeting Protects Against the Acute Phase of Graft Versus Host Reaction by Inhibiting Donor Anti-Host Cytotoxicity TRANSPLANTATION
Artículo2011 Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens LEUKEMIA RESEARCH
Letter2011 Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant BONE MARROW TRANSPLANTATION
Artículo2011 Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study TRANSPLANTATION PROCEEDINGS
Letter2011 Effect of vitamin D treatment in chronic GVHD BONE MARROW TRANSPLANTATION
Artículo2011 Helicobacter pylori Infection and Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011 Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease IMMUNOLOGY LETTERS
Artículo2011 Limbus Damage in Ocular Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011 Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial HAEMATOLOGICA
Artículo2011 Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2011 Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System BLOOD
Artículo2010 Both CD133+ cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells Cell Transplantation
Artículo2010 Chronic graft-versus-host disease METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Artículo2010 Current role of allogeneic transplantation in patients with multiple myeloma: Results and recommendations in February 2010 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Revisión2010 European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma LEUKEMIA & LYMPHOMA
Artículo2010 Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting BLOOD
Revisión2010 Immunomodulatory effect of mesenchymal stem cells Brazilian Journal of Medical and Biological Research
Revisión2010 International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma JOURNAL OF CLINICAL ONCOLOGY
Letter2010 Liver function tests and absolute lymphocyte count at day+100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant AMERICAN JOURNAL OF HEMATOLOGY
Artículo2010 P22(phox)-dependent NADPH oxidase activity is required for megakaryocytic differentiation CELL DEATH AND DIFFERENTIATION
Artículo2009 Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Ponencia2009 Allogenic stem cell transplant in MDS: results of the Spanish registry LEUKEMIA RESEARCH
Artículo2009 Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome LEUKEMIA
Artículo2009 Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy TRANSFUSION
Artículo2009 Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura CYTOTHERAPY
Artículo2009 Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies AMERICAN JOURNAL OF HEMATOLOGY
Artículo2009 Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2009 Treatment with bortezomib of human CD4(+) T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population HAEMATOLOGICA
Artículo2008 A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma BLOOD
Artículo2008 Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Artículo2008 Clinical and Prognostic Value of Discrepancies in Microsatellite DNA Regions Between Recipient and Donor in Human Leukocyte Antigen-Identical Allogeneic Transplantation Setting TRANSPLANTATION
Artículo2008 Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation HAEMATOLOGICA
Corrección2008 Erratum: "Beclometasone dipropionate: A topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease" (Expert Opinion on Investigational Drugs (2008) vol. 17(9) (1389-1401)) Expert Opinion on Investigational Drugs
Corrección2008 Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (vol 22, pg 1250, 2008) LEUKEMIA
Revisión2008 Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Artículo2008 Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: The national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2008 Prognostic impact of pre-transplantation computed tomography and (67)gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation ANNALS OF NUCLEAR MEDICINE
Artículo2008 Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients TRANSFUSION
Artículo2008 Reduced-intensity conditioning allogeneic transplantation from unrelated donors: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2008 Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: Chronic graft-versus-host disease is the strongest factor improving survival JOURNAL OF CLINICAL ONCOLOGY
Artículo2008 The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes HAEMATOLOGICA
Artículo2007 In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression TRANSFUSION AND APHERESIS SCIENCE
Artículo2007 Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome HAEMATOLOGICA
Artículo2007 Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers CYTOTHERAPY
Artículo2007 Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Letter2007 Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation HAEMATOLOGICA
Letter2006 Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation EXPERIMENTAL HEMATOLOGY
Artículo2006 Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines BLOOD
Revisión2006 Chronic graft-versus-host disease: Pathogenesis and clinical management DRUGS
Artículo2006 Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation LEUKEMIA & LYMPHOMA
Artículo2006 G-CSF increases the number of peripheral blood dendritic cells CD16+and modifies the expression of the costimulatory molecule CD86+ BONE MARROW TRANSPLANTATION
Artículo2006 Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2006 Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma BONE MARROW TRANSPLANTATION
Artículo2006 Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation CLINICAL LYMPHOMA & MYELOMA
Letter2006 Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients LEUKEMIA
Letter2006 Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma BLOOD
Letter2006 Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy BONE MARROW TRANSPLANTATION
Artículo2005 CD34+cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation LEUKEMIA & LYMPHOMA
Artículo2005 Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma HAEMATOLOGICA
Artículo2005 Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation BRITISH JOURNAL OF HAEMATOLOGY
Artículo2005 Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors HAEMATOLOGICA
Artículo2005 Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2005 Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability EXPERIMENTAL HEMATOLOGY
Resumen congreso2005 Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease BONE MARROW TRANSPLANTATION
Artículo2005 Reduced-intensity conditioning stem cell transplantation with allogeneic blood fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2004 Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo2004 Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience ANNALS OF ONCOLOGY
Artículo2004 Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation BLOOD
Artículo2004 Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma BONE MARROW TRANSPLANTATION
Artículo2004 Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial BONE MARROW TRANSPLANTATION
Artículo2004 Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantation LEUKEMIA & LYMPHOMA
Artículo2004 Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation HAEMATOLOGICA
Letter2004 Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients - Reply BONE MARROW TRANSPLANTATION
Artículo2004 Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study BONE MARROW TRANSPLANTATION
Artículo2004 QUALITY OF LIFE ASSESSMENT IN PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC VS AUTOLOGOUS TRANSPLANTATION: RESULTS OF A PROSPECTIVE STUDY BONE MARROW TRANSPLANTATION
Artículo2004 Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2004 REPLY ON BEHALF OF THE AUTHORS. BONE MARROW TRANSPLANTATION
Artículo2004 RESULTS AFTER AUTOLOGOUS LYMPHOMA TRANSPLANTATION ARE NOT IMPROVED BY INCREASING THE DOSE OF ETOPOSIDE IN THE BEAM REGIMEN: A SINGLE-CENTRE SEQUENTIAL COHORT STUDY. BONE MARROW TRANSPLANTATION
Artículo2004 Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study BONE MARROW TRANSPLANTATION
Artículo2003 Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning BONE MARROW TRANSPLANTATION
Artículo2003 Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation BRITISH JOURNAL OF HAEMATOLOGY
Artículo2003 High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group ANNALS OF ONCOLOGY
Artículo2003 Impact of CD34(+) cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation BLOOD
Artículo2002 Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation LEUKEMIA
Artículo2002 Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes BLOOD
Artículo2002 Influence of the different CD34(+) and CD34(-) cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors BRITISH JOURNAL OF HAEMATOLOGY
Letter2002 Intensive monitoring program for oral food intake in patients undergoing allogeneic hematopoietic cell transplantation: A cost-benefit analysis NUTRITION
Artículo2002 Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders BLOOD
Artículo2002 The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen TRANSFUSION
Artículo2001 Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study BRITISH JOURNAL OF HAEMATOLOGY
Editorial2001 Debate round-table: Comments concerning chimerism studies LEUKEMIA
Artículo2001 Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease BRITISH JOURNAL OF HAEMATOLOGY
Artículo2001 Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo2000 ARE MYELOMA PATIENTS WITH RENAL FAILURE CANDIDATES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION? Hematology Journal
Artículo2000 Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo2000 Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation BONE MARROW TRANSPLANTATION
Artículo1999 Clinical significance of CD34(+) cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo1999 Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma CYTOMETRY
Artículo1999 Neurological complications after autologous stem cell transplantation EUROPEAN NEUROLOGY
Artículo1999 Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics BLOOD
Artículo1999 Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors CYTOMETRY
Artículo1998 Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells CYTOMETRY
Revisión1998 Fulminant angiopathy caused by allogenic transplantation of bone marrow with cerebral involvement: clinico-pathologic correlation ANALES DE MEDICINA INTERNA
Artículo1998 Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation TRANSFUSION
Artículo1998 Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes BLOOD
Artículo1997 Complete cytogenetic but not molecular remission in a patient with myeloid blast crisis of chronic myeloid leukemia treated with carboplatin and ARA-C HAEMATOLOGICA
Artículo1997 Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics ANNALS OF HEMATOLOGY
Letter1997 Lymph node myeloid metaplasia associated with chronic neutrophilic leukemia HAEMATOLOGICA
Letter1997 Lymph node myeloid metaplasia associated with chronic neutrophilic leukemia. HAEMATOLOGICA
Artículo1997 Minimal number of circulating CD34+ cells to assure successful leukapheresis and engraftment in peripheral blood progenitor cell transplantation Infusionstherapie und Transfusionsmedizin
Artículo1997 Trasplante autólogo con esquema BEAM en linfoma SANGRE
Artículo1996 Incidence of chromosome numerical changes in multiple myeloma: Fluorescence in situ hybridization analysis using 15 chromosome-specific probes AMERICAN JOURNAL OF PATHOLOGY
Revisión1996 Management of multiple myeloma (I): Role of chemotherapy, interferon and support therapy Inflamacion y Regulacion del Crecimiento Celular
Revisión1996 Management of multiple myeloma (II): Allogenic and autologous bone marrow transplantation Inflamacion y Regulacion del Crecimiento Celular
El investigador no tiene ningún proyecto asociado